Loading…

YKL-40 and mesothelin in the blood of patients with malignant mesothelioma, lung cancer and asbestosis

In the diagnosis of malignant mesothelioma (MM) there still is a lack of specific and sensitive screening biomarkers: this study examined the discriminatory power of a panel of serum/plasma biomarkers. The study involved four groups: (a) individuals previously exposed to asbestos with asbestosis; (b...

Full description

Saved in:

Bibliographic Details
Published in:	Anticancer research 2013-12, Vol.33 (12), p.5517-5524
Main Authors:	Corradi, Massimo, Goldoni, Matteo, Alinovi, Rossella, Tiseo, Marcello, Ampollini, Luca, Bonini, Silvia, Carbognani, Paolo, Casalini, Angelo, Mutti, Antonio
Format:	Article
Language:	English
Subjects:	Adipokines - blood Aged Asbestosis - blood Biomarkers, Tumor - blood Case-Control Studies Chitinase-3-Like Protein 1 Cross-Sectional Studies Endothelin-1 - blood Female GPI-Linked Proteins - blood Humans Interleukin-8 - blood Lectins - blood Lung Neoplasms - blood Male Mesothelioma - blood Middle Aged Vascular Endothelial Growth Factor A - blood
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by
cites
container_end_page	5524
container_issue	12
container_start_page	5517
container_title	Anticancer research
container_volume	33
creator	Corradi, Massimo Goldoni, Matteo Alinovi, Rossella Tiseo, Marcello Ampollini, Luca Bonini, Silvia Carbognani, Paolo Casalini, Angelo Mutti, Antonio
description	In the diagnosis of malignant mesothelioma (MM) there still is a lack of specific and sensitive screening biomarkers: this study examined the discriminatory power of a panel of serum/plasma biomarkers. The study involved four groups: (a) individuals previously exposed to asbestos with asbestosis; (b) patients with MM; (c) patients with non-small cell lung cancer; and (d) controls without any evidence of malignancy. The concentrations of mesothelin, chitinase-3-like-1 (YKL-40), vascular endothelial growth factor (VEGF), endothelin-1, interleukin-8 (IL-8) and fibulin-3 in the serum of patients were determined. Patients with MM had significantly higher serum levels of mesothelin (p
format	article
fullrecord	<record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1467063393</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1467063393</sourcerecordid><originalsourceid>FETCH-LOGICAL-p211t-26b48e32aa61382da44984e5192739051fd21c57d364a66f5d7a899f344edab53</originalsourceid><addsrcrecordid>eNpFUEtLxDAYDIK46-pfkBw9WEjypWlzlMUXLnjRg6fytUl3I2lSmxTx31t8IAzMHOYBc0TWvNK8qEpgK3Ka0htjSukaTshKSBCSab4m_evjrpCMYjB0sCnmg_Uu0AWLoq2P0dDY0xGzsyEn-uHygQ7o3T5gyP-ROOAV9XPY0w5DZ6fvQkytTTkml87IcY8-2fNf3pCX25vn7X2xe7p72F7vilFwnguhWllbEIiKQy0MSqlraUuuRQWalbw3gndlZUBJVKovTYW11j1IaQ22JWzI5U_vOMX3eRlvBpc66z0GG-fUcKkqpgA0LNaLX-vcDtY04-QGnD6bv2_gC4nQXp4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1467063393</pqid></control><display><type>article</type><title>YKL-40 and mesothelin in the blood of patients with malignant mesothelioma, lung cancer and asbestosis</title><source>EZB Electronic Journals Library</source><creator>Corradi, Massimo ; Goldoni, Matteo ; Alinovi, Rossella ; Tiseo, Marcello ; Ampollini, Luca ; Bonini, Silvia ; Carbognani, Paolo ; Casalini, Angelo ; Mutti, Antonio</creator><creatorcontrib>Corradi, Massimo ; Goldoni, Matteo ; Alinovi, Rossella ; Tiseo, Marcello ; Ampollini, Luca ; Bonini, Silvia ; Carbognani, Paolo ; Casalini, Angelo ; Mutti, Antonio</creatorcontrib><description>In the diagnosis of malignant mesothelioma (MM) there still is a lack of specific and sensitive screening biomarkers: this study examined the discriminatory power of a panel of serum/plasma biomarkers. The study involved four groups: (a) individuals previously exposed to asbestos with asbestosis; (b) patients with MM; (c) patients with non-small cell lung cancer; and (d) controls without any evidence of malignancy. The concentrations of mesothelin, chitinase-3-like-1 (YKL-40), vascular endothelial growth factor (VEGF), endothelin-1, interleukin-8 (IL-8) and fibulin-3 in the serum of patients were determined. Patients with MM had significantly higher serum levels of mesothelin (p<0.001), YKL-40 (p<0.001), IL-8 (p<0.001) and VEGF (p<0.01) than controls. The cut-off point for MM was 1.26 nM for mesothelin alone, and 167 pg/ml for YKL-40 alone; the presence of both markers above these cut-off levels improved diagnostic specificity. The addition of YKL-40 may improve the specificity of mesothelin measurements alone for detecting patients with MM.</description><identifier>EISSN: 1791-7530</identifier><identifier>PMID: 24324091</identifier><language>eng</language><publisher>Greece</publisher><subject>Adipokines - blood ; Aged ; Asbestosis - blood ; Biomarkers, Tumor - blood ; Case-Control Studies ; Chitinase-3-Like Protein 1 ; Cross-Sectional Studies ; Endothelin-1 - blood ; Female ; GPI-Linked Proteins - blood ; Humans ; Interleukin-8 - blood ; Lectins - blood ; Lung Neoplasms - blood ; Male ; Mesothelioma - blood ; Middle Aged ; Vascular Endothelial Growth Factor A - blood</subject><ispartof>Anticancer research, 2013-12, Vol.33 (12), p.5517-5524</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24324091$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Corradi, Massimo</creatorcontrib><creatorcontrib>Goldoni, Matteo</creatorcontrib><creatorcontrib>Alinovi, Rossella</creatorcontrib><creatorcontrib>Tiseo, Marcello</creatorcontrib><creatorcontrib>Ampollini, Luca</creatorcontrib><creatorcontrib>Bonini, Silvia</creatorcontrib><creatorcontrib>Carbognani, Paolo</creatorcontrib><creatorcontrib>Casalini, Angelo</creatorcontrib><creatorcontrib>Mutti, Antonio</creatorcontrib><title>YKL-40 and mesothelin in the blood of patients with malignant mesothelioma, lung cancer and asbestosis</title><title>Anticancer research</title><addtitle>Anticancer Res</addtitle><description>In the diagnosis of malignant mesothelioma (MM) there still is a lack of specific and sensitive screening biomarkers: this study examined the discriminatory power of a panel of serum/plasma biomarkers. The study involved four groups: (a) individuals previously exposed to asbestos with asbestosis; (b) patients with MM; (c) patients with non-small cell lung cancer; and (d) controls without any evidence of malignancy. The concentrations of mesothelin, chitinase-3-like-1 (YKL-40), vascular endothelial growth factor (VEGF), endothelin-1, interleukin-8 (IL-8) and fibulin-3 in the serum of patients were determined. Patients with MM had significantly higher serum levels of mesothelin (p<0.001), YKL-40 (p<0.001), IL-8 (p<0.001) and VEGF (p<0.01) than controls. The cut-off point for MM was 1.26 nM for mesothelin alone, and 167 pg/ml for YKL-40 alone; the presence of both markers above these cut-off levels improved diagnostic specificity. The addition of YKL-40 may improve the specificity of mesothelin measurements alone for detecting patients with MM.</description><subject>Adipokines - blood</subject><subject>Aged</subject><subject>Asbestosis - blood</subject><subject>Biomarkers, Tumor - blood</subject><subject>Case-Control Studies</subject><subject>Chitinase-3-Like Protein 1</subject><subject>Cross-Sectional Studies</subject><subject>Endothelin-1 - blood</subject><subject>Female</subject><subject>GPI-Linked Proteins - blood</subject><subject>Humans</subject><subject>Interleukin-8 - blood</subject><subject>Lectins - blood</subject><subject>Lung Neoplasms - blood</subject><subject>Male</subject><subject>Mesothelioma - blood</subject><subject>Middle Aged</subject><subject>Vascular Endothelial Growth Factor A - blood</subject><issn>1791-7530</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNpFUEtLxDAYDIK46-pfkBw9WEjypWlzlMUXLnjRg6fytUl3I2lSmxTx31t8IAzMHOYBc0TWvNK8qEpgK3Ka0htjSukaTshKSBCSab4m_evjrpCMYjB0sCnmg_Uu0AWLoq2P0dDY0xGzsyEn-uHygQ7o3T5gyP-ROOAV9XPY0w5DZ6fvQkytTTkml87IcY8-2fNf3pCX25vn7X2xe7p72F7vilFwnguhWllbEIiKQy0MSqlraUuuRQWalbw3gndlZUBJVKovTYW11j1IaQ22JWzI5U_vOMX3eRlvBpc66z0GG-fUcKkqpgA0LNaLX-vcDtY04-QGnD6bv2_gC4nQXp4</recordid><startdate>201312</startdate><enddate>201312</enddate><creator>Corradi, Massimo</creator><creator>Goldoni, Matteo</creator><creator>Alinovi, Rossella</creator><creator>Tiseo, Marcello</creator><creator>Ampollini, Luca</creator><creator>Bonini, Silvia</creator><creator>Carbognani, Paolo</creator><creator>Casalini, Angelo</creator><creator>Mutti, Antonio</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201312</creationdate><title>YKL-40 and mesothelin in the blood of patients with malignant mesothelioma, lung cancer and asbestosis</title><author>Corradi, Massimo ; Goldoni, Matteo ; Alinovi, Rossella ; Tiseo, Marcello ; Ampollini, Luca ; Bonini, Silvia ; Carbognani, Paolo ; Casalini, Angelo ; Mutti, Antonio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p211t-26b48e32aa61382da44984e5192739051fd21c57d364a66f5d7a899f344edab53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adipokines - blood</topic><topic>Aged</topic><topic>Asbestosis - blood</topic><topic>Biomarkers, Tumor - blood</topic><topic>Case-Control Studies</topic><topic>Chitinase-3-Like Protein 1</topic><topic>Cross-Sectional Studies</topic><topic>Endothelin-1 - blood</topic><topic>Female</topic><topic>GPI-Linked Proteins - blood</topic><topic>Humans</topic><topic>Interleukin-8 - blood</topic><topic>Lectins - blood</topic><topic>Lung Neoplasms - blood</topic><topic>Male</topic><topic>Mesothelioma - blood</topic><topic>Middle Aged</topic><topic>Vascular Endothelial Growth Factor A - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Corradi, Massimo</creatorcontrib><creatorcontrib>Goldoni, Matteo</creatorcontrib><creatorcontrib>Alinovi, Rossella</creatorcontrib><creatorcontrib>Tiseo, Marcello</creatorcontrib><creatorcontrib>Ampollini, Luca</creatorcontrib><creatorcontrib>Bonini, Silvia</creatorcontrib><creatorcontrib>Carbognani, Paolo</creatorcontrib><creatorcontrib>Casalini, Angelo</creatorcontrib><creatorcontrib>Mutti, Antonio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Anticancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Corradi, Massimo</au><au>Goldoni, Matteo</au><au>Alinovi, Rossella</au><au>Tiseo, Marcello</au><au>Ampollini, Luca</au><au>Bonini, Silvia</au><au>Carbognani, Paolo</au><au>Casalini, Angelo</au><au>Mutti, Antonio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>YKL-40 and mesothelin in the blood of patients with malignant mesothelioma, lung cancer and asbestosis</atitle><jtitle>Anticancer research</jtitle><addtitle>Anticancer Res</addtitle><date>2013-12</date><risdate>2013</risdate><volume>33</volume><issue>12</issue><spage>5517</spage><epage>5524</epage><pages>5517-5524</pages><eissn>1791-7530</eissn><abstract>In the diagnosis of malignant mesothelioma (MM) there still is a lack of specific and sensitive screening biomarkers: this study examined the discriminatory power of a panel of serum/plasma biomarkers. The study involved four groups: (a) individuals previously exposed to asbestos with asbestosis; (b) patients with MM; (c) patients with non-small cell lung cancer; and (d) controls without any evidence of malignancy. The concentrations of mesothelin, chitinase-3-like-1 (YKL-40), vascular endothelial growth factor (VEGF), endothelin-1, interleukin-8 (IL-8) and fibulin-3 in the serum of patients were determined. Patients with MM had significantly higher serum levels of mesothelin (p<0.001), YKL-40 (p<0.001), IL-8 (p<0.001) and VEGF (p<0.01) than controls. The cut-off point for MM was 1.26 nM for mesothelin alone, and 167 pg/ml for YKL-40 alone; the presence of both markers above these cut-off levels improved diagnostic specificity. The addition of YKL-40 may improve the specificity of mesothelin measurements alone for detecting patients with MM.</abstract><cop>Greece</cop><pmid>24324091</pmid><tpages>8</tpages></addata></record>
fulltext	fulltext
identifier	EISSN: 1791-7530
ispartof	Anticancer research, 2013-12, Vol.33 (12), p.5517-5524
issn	1791-7530
language	eng
recordid	cdi_proquest_miscellaneous_1467063393
source	EZB Electronic Journals Library
subjects	Adipokines - blood Aged Asbestosis - blood Biomarkers, Tumor - blood Case-Control Studies Chitinase-3-Like Protein 1 Cross-Sectional Studies Endothelin-1 - blood Female GPI-Linked Proteins - blood Humans Interleukin-8 - blood Lectins - blood Lung Neoplasms - blood Male Mesothelioma - blood Middle Aged Vascular Endothelial Growth Factor A - blood
title	YKL-40 and mesothelin in the blood of patients with malignant mesothelioma, lung cancer and asbestosis
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T19%3A32%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=YKL-40%20and%20mesothelin%20in%20the%20blood%20of%20patients%20with%20malignant%20mesothelioma,%20lung%20cancer%20and%20asbestosis&rft.jtitle=Anticancer%20research&rft.au=Corradi,%20Massimo&rft.date=2013-12&rft.volume=33&rft.issue=12&rft.spage=5517&rft.epage=5524&rft.pages=5517-5524&rft.eissn=1791-7530&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E1467063393%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p211t-26b48e32aa61382da44984e5192739051fd21c57d364a66f5d7a899f344edab53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1467063393&rft_id=info:pmid/24324091&rfr_iscdi=true